Published in J Urol on February 01, 1980
Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol (2008) 1.91
Ureterolithotripsy in a paediatric population: a single institution's experience. Urolithiasis (2013) 0.78
Evaluation of urinary abnormalities in nephrolithiasis patients from Marathwada region. Indian J Clin Biochem (2006) 0.76
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol (2001) 3.26
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10
Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int (1995) 1.68
Platelet dysfunction in type 2 diabetes. Diabetes Care (2001) 1.66
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med (1995) 1.63
Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol (2000) 1.62
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57
Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med (1987) 1.53
The natural history of asymptomatic urolithiasis. J Urol (1992) 1.49
Skin prick testing and peanut-specific IgE can predict peanut challenge outcomes in preschoolchildren with peanut sensitization. Clin Exp Allergy (2011) 1.47
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine. J Clin Gastroenterol (2001) 1.44
Calcium antagonists and acute renal failure. Am J Med (1989) 1.43
Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33
Epithelial giant cells in measles as an acid in diagnosis. J Pediatr (1970) 1.32
Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology. J Am Soc Nephrol (1999) 1.26
Association between hydrocarbon exposure and glomerulonephritis. An appraisal of the evidence. Nephron (1983) 1.24
Clinimetrics in nephrology. Nephron (1986) 1.18
Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int (2000) 1.18
Potentially lethal interaction of cimetidine and morphine. Can Med Assoc J (1981) 1.16
To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ (2000) 1.13
Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int (1997) 1.08
The quality of life in renal transplantation--a prospective study. Transplantation (1992) 1.08
Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant (2000) 1.03
Cadaver kidney transplants. Transplantation (1967) 1.02
Analgesic nephropathy. A clinicopathologic study using electron microscopy. Am J Med (1971) 1.02
Urolithiasis complicating inflammatory bowel disease. J Urol (1992) 1.02
Improvements in drug prescription labels for patients with limited education or vision. Can Med Assoc J (1982) 1.01
Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J (1968) 1.01
Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol (2001) 1.00
Cerebral and pontine myelinolysis. Two cases with fluid and electrolyte imbalance and hypotension. J Neurol Sci (1973) 0.98
Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant (2013) 0.97
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int (2000) 0.97
Renal disease-a sixth cardinal feature of the Laurence-Moon-Biedl syndrome. Clin Nephrol (1981) 0.95
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal. Miner Electrolyte Metab (1987) 0.94
Real-time ultrasound imaging aids jugular venipuncture. Anesth Analg (1989) 0.94
Glomerular injury in patients with neoplasia. Annu Rev Med (1976) 0.93
"Sneaky disease": the body and health knowledge for people at risk for coronary heart disease in Ontario, Canada. Soc Sci Med (2004) 0.93
Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant (2001) 0.92
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl (1996) 0.90
Left ventricular hypertrophy in end-stage renal disease. Nephron (1988) 0.90
Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron (1988) 0.88
Kidney transplantation and long-term dialysis. Am Heart J (1970) 0.88
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Polymorphonuclear leucocytic activity in malnourished children. Cent Afr J Med (1972) 0.87
Analgesic nephropathy, 1972-76. Can Med Assoc J (1977) 0.87
Economic evaluation of extracorporeal shock wave lithotripsy, percutaneous ultrasonic lithotripsy, and standard surgical treatment of urolithiasis--a Canadian perspective. Clin Invest Med (1987) 0.87
Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet (1994) 0.87
Effect of some drugs on clinical laboratory values as determined by the Technicon SMA 12-60. Clin Chem (1972) 0.86
Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J (1973) 0.86
Clinical significance of urinary LDH, alkaline phosphatase and other enzymes. Can Med Assoc J (1969) 0.86
HLA disease association and protection in HIV infection among African Americans and Caucasians. Pathobiology (1991) 0.85
Metabolic investigation of recurrent nephrolithiasis: compliance with recommendations. Urology (2000) 0.85
Renal biopsy: current views and controversies. Nephron (1983) 0.84
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int (1978) 0.84
Biotransformation and elimination of digoxin with normal and minimal renal function. Clin Pharmacol Ther (1979) 0.83
The plasma phenolsulfonphthalein index (PSPI) of renal function: I. Theoretical considerations and investigative studies. Can Med Assoc J (1966) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
Persisting renal insufficiency after methoxyflurane anesthesia. Report of two cases and review of literature. Am J Med (1974) 0.83
Significance of a negative cross match in recipients with a wide spectrum of lymphocytotoxic antibodies. Transplantation (1971) 0.83
Chronic pyelonephritis: relative incidence in transplant recipients. N Engl J Med (1966) 0.82
Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br J Urol (1967) 0.82
Hyperchloremic acidosis in early diagnosis of renal allograft rejection. Ann Intern Med (1969) 0.82
Comparison of infrared and wet chemical analysis of urinary tract calculi. Clin Chim Acta (1980) 0.81
Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol (1992) 0.81
Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity. Biochem Genet (1983) 0.81
Plasma digitalis-like factor(s) increase with salt loading. N Engl J Med (1983) 0.81
Studies of digoxin dosage, kinetics and serum concentrations in renal failure and review of the literature. Nephron (1976) 0.80
Uterine prolapse and renal dysfunction. J Urol (1980) 0.80
Development of lymphocytotoxic antibodies in hemodialysis patients. Vox Sang (1972) 0.80
Serum and urinary enzyme activity after renal infarction. Can Med Assoc J (1965) 0.80
Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase. Can Med Assoc J (1967) 0.80
Evidence for the nephrotoxicity of analgesics. Can Med Assoc J (1972) 0.80
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions. Ann Intern Med (1971) 0.79
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days. Can Med Assoc J (1969) 0.79
Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. Kidney Int (2000) 0.79
Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20. J Chromatogr (1976) 0.79
Preservation of the dog kidney. J Surg Res (1968) 0.79
Proteinuria in Hashimoto thyroiditis. N Engl J Med (1981) 0.79
The oxalate:phosphate ratio in urinary tract calculi by infrared revised analysis. Clin Chim Acta (1987) 0.78
Thiazides for patients with recurrent calcium stones: still an open question. J Urol (1985) 0.78
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values. Gastroenterology (1966) 0.78
A model phosphatase 2C --> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liver. Biochem Biophys Res Commun (1999) 0.78